Discovery Ventures

Discovery Ventures is a leading biotech-focused VC team with a proven track record of success. Our powerhouse team members have been responsible for the most successful achievements in the field of Next Generation BioTechnology globally, bringing the first and second approved gene therapies to market, along with the first and second stem cell therapy approvals. Over two decades, we have forged partnerships with leading biotech venture capital firms across the US and Europe, where our unparalleled expertise in key technologies – including Gene Therapy, Advanced Cell therapy, Bionics, Tissue Engineering, and Nanotechnology – earns us a coveted seat at the table as co-investors in groundbreaking deals. With offices in Paris, London, and New York, we primarily invest in European and US-based Series A+ next-generation biomedical technology companies.